Patent · US Active

Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA

US10954296B2 · kind B2 · utility

3Cited by

8References

51Claims

0Family size

Assignee

Visterra, Inc. · US

Inventors

James R. Myette · Waltham, US
Zachary Shriver · Winchester, US
Karthik Viswanathan · Waltham, US
Andrew M. Wollacott · Boston, US
Hedy Adari-Hall · Sudbury, US
Boopathy Ramakrishnan · Braintree, US
Gregory Babcock · Marlborough, US

Key dates

Filing date	Jun 10, 2020
Grant date	Mar 23, 2021
Priority date	—
Expiry date	Jun 10, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibody molecules that specifically bind to APRIL are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as IgA nephropathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.